Literature DB >> 27246735

tRNA modification profiles of the fast-proliferating cancer cells.

Chao Dong1, Leilei Niu1, Wei Song1, Xin Xiong2, Xianhua Zhang2, Zhenxi Zhang1, Yi Yang1, Fan Yi1, Jun Zhan3, Hongquan Zhang3, Zhenjun Yang1, Li-He Zhang1, Suodi Zhai2, Hua Li4, Min Ye5, Quan Du6.   

Abstract

Despite the recent progress in RNA modification study, a comprehensive modification profile is still lacking for mammalian cells. Using a quantitative HPLC/MS/MS assay, we present here a study where RNA modifications are examined in term of the major RNA species. With paired slow- and fast-proliferating cell lines, distinct RNA modification profiles are first revealed for diverse RNA species. Compared to mRNAs, increased ribose and nucleobase modifications are shown for the highly-structured tRNAs and rRNAs, lending support to their contribution to the formation of high-order structures. This study also reveals a dynamic tRNA modification profile in the fast-proliferating cells. In addition to cultured cells, this unique tRNA profile has been further confirmed with endometrial cancers and their adjacent normal tissues. Taken together, the results indicate that tRNA is a actively regulated RNA species in the fast-proliferating cancer cells, and suggest that they may play a more active role in biological process than expected.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Proliferation; RNA modification

Mesh:

Substances:

Year:  2016        PMID: 27246735     DOI: 10.1016/j.bbrc.2016.05.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Signaling to and from the RNA Polymerase III Transcription and Processing Machinery.

Authors:  Ian M Willis; Robyn D Moir
Journal:  Annu Rev Biochem       Date:  2018-01-12       Impact factor: 23.643

Review 2.  The epitranscriptome beyond m6A.

Authors:  David Wiener; Schraga Schwartz
Journal:  Nat Rev Genet       Date:  2020-11-13       Impact factor: 53.242

3.  Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine.

Authors:  Daniel Arango; David Sturgill; Renbin Yang; Tapan Kanai; Paulina Bauer; Jyoti Roy; Ziqiu Wang; Masaki Hosogane; Sarah Schiffers; Shalini Oberdoerffer
Journal:  Mol Cell       Date:  2022-06-08       Impact factor: 19.328

4.  Acetylation of Cytidine in mRNA Promotes Translation Efficiency.

Authors:  Daniel Arango; David Sturgill; Najwa Alhusaini; Allissa A Dillman; Thomas J Sweet; Gavin Hanson; Masaki Hosogane; Wilson R Sinclair; Kyster K Nanan; Mariana D Mandler; Stephen D Fox; Thomas T Zengeya; Thorkell Andresson; Jordan L Meier; Jeffery Coller; Shalini Oberdoerffer
Journal:  Cell       Date:  2018-11-15       Impact factor: 41.582

5.  Acetylation takes aim at mRNA.

Authors:  Seung H Choi; Kate D Meyer
Journal:  Nat Struct Mol Biol       Date:  2018-12       Impact factor: 15.369

6.  Immunoprecipitation and Sequencing of Acetylated RNA.

Authors:  Daniel Arango; David Sturgill; Shalini Oberdoerffer
Journal:  Bio Protoc       Date:  2019-06-20

Review 7.  Genome recoding by tRNA modifications.

Authors:  Francesca Tuorto; Frank Lyko
Journal:  Open Biol       Date:  2016-12       Impact factor: 6.411

8.  PACES: prediction of N4-acetylcytidine (ac4C) modification sites in mRNA.

Authors:  Wanqing Zhao; Yiran Zhou; Qinghua Cui; Yuan Zhou
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

Review 9.  Mapping the epigenetic modifications of DNA and RNA.

Authors:  Lin-Yong Zhao; Jinghui Song; Yibin Liu; Chun-Xiao Song; Chengqi Yi
Journal:  Protein Cell       Date:  2020-05-22       Impact factor: 14.870

10.  FTSJ1 regulates tRNA 2'-O-methyladenosine modification and suppresses the malignancy of NSCLC via inhibiting DRAM1 expression.

Authors:  Qihan He; Lin Yang; Kaiping Gao; Peikun Ding; Qianqian Chen; Juan Xiong; Wenhan Yang; Yi Song; Liang Wang; Yejun Wang; Lijuan Ling; Weiming Wu; Jisong Yan; Peng Zou; Yuchen Chen; Rihong Zhai
Journal:  Cell Death Dis       Date:  2020-05-11       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.